Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP
Report ID | 235273 |
Drug Identification Number | 02325624 |
Brand name | CEFTRIAXONE SODIUM FOR INJECTION BP |
Common or Proper name | CEFTRIAXONE SODIUM FOR INJECTION BP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | CEFTRIAXONE |
Strength(s) | 2G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 10 X 2 G VIAL |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-08-23 |
Actual start date | |
Estimated end date | 2024-12-30 |
Actual end date | 2024-12-19 |
Shortage status | Resolved |
Updated date | 2024-12-20 |
Company comments | Product is on allocation at 100% at McKesson. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-12-20 | English | Compare |
v11 | 2024-12-19 | French | Compare |
v10 | 2024-12-19 | English | Compare |
v9 | 2024-12-12 | French | Compare |
v8 | 2024-12-12 | English | Compare |
v7 | 2024-10-25 | French | Compare |
v6 | 2024-10-25 | English | Compare |
v5 | 2024-10-01 | French | Compare |
v4 | 2024-10-01 | English | Compare |
v3 | 2024-08-24 | English | Compare |
v2 | 2024-08-15 | French | Compare |
v1 | 2024-08-15 | English | Compare |
Showing 1 to 12 of 12